{
    "eid": "2-s2.0-85059820426",
    "title": "Revisit Roles of HTA on Drug Policy in Universal Health Coverage in Thailand: Where Are We? And What Is Next?",
    "cover-date": "2019-05-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Economics, Econometrics and Finance (miscellaneous)",
            "@code": "2001",
            "@abbrev": "ECON"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology, Toxicology and Pharmaceutics (miscellaneous)",
            "@code": "3001",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Health Policy",
            "@code": "2719",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "drug policy",
        "health technology assessment",
        "Thailand",
        "universal health coverage"
    ],
    "authors": [
        "Pimwara Tanvejsilp",
        "Suthira Taychakhoonavudh",
        "Usa Chaikledkaew",
        "Nathorn Chaiyakunapruk",
        "Surachat Ngorsuraches"
    ],
    "citedby-count": 8,
    "ref-count": 26,
    "ref-list": [
        "Thailand health financing review 2010",
        "Funding, coverage, and access under Thailand's universal health insurance program: an update after ten years",
        "The Kingdom of Thailand Health System Review (Health Systems in Transition)",
        "WHA67.23\u2014Health intervention and technology assessment in support of universal health coverage. WHA resolution. Sixty-Seventh World Health Assembly, 2014",
        "EUR-ASSESS project subgroup report on methodology: methodological guidance for the conduct of health technology assessment",
        "Assessing the Efficacy and Safety of Medical Technologies",
        "Best practice in undertaking and reporting health technology assessments. Working group 4 report",
        "Health care resource utilization statistical report",
        "ISafE and the evidence-based approach for essential medicines selection in Thailand",
        "Appropriate Threshold in Thailand. Subcommittee for the Development of the National List of Essential Medicines Meeting 9/2550",
        "Thailand now an upper middle income economy",
        "Assessing a Social Value for a Ceiling Threshold in Thailand",
        "The use of economic evaluation for guiding the pharmaceutical reimbursement list in Thailand",
        "Essential medicines for universal health coverage",
        "Order of Appointment from the Subcommittee for Development of the National List of Essential Medicines 3/2549",
        "Economic evaluation of palliative management versus peritoneal dialysis and hemodialysis for end-stage renal disease: evidence for coverage decisions in Thailand",
        "Is a HIV vaccine a viable option and at what price? An economic evaluation of adding HIV vaccination into existing prevention programs in Thailand",
        "The current capacity and future development of economic evaluation for policy decision-making: a survey among researchers and decision-makers in Thailand",
        "Annual report 2015 Health Intervention and Technology Assessment Program (HITAP)",
        "Economic evaluation of policy options for prevention and control of cervical cancer in Thailand",
        "A learning experience from price negotiations for vaccines",
        "Cervical cancer screening in Thailand: an overview",
        "Institutionalising health technology assessment: establishing the Medical Technology Assessment Board in India",
        "Economic evaluation of policy options for dialysis in end-stage renal disease patients under the universal health coverage in Indonesia",
        "Vaccination program in a resource-limited setting: a case study in the Philippines",
        "Health financing lessons from Thailand for South Africa on the path towards universal health coverage"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bandar Sunway",
            "@id": "60018894",
            "affilname": "Monash University Malaysia",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018894",
            "affiliation-country": "Malaysia"
        },
        {
            "affiliation-city": "Nakhon Pathom",
            "@id": "60012718",
            "affilname": "Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Madison",
            "@id": "60032179",
            "affilname": "University of Wisconsin-Madison",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032179",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pitsanulok",
            "@id": "60022498",
            "affilname": "Naresuan University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022498",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Hatyai",
            "@id": "60006314",
            "affilname": "Prince of Songkla University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006314",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Auburn",
            "@id": "60001085",
            "affilname": "Harrison School of Pharmacy",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60001085",
            "affiliation-country": "United States"
        }
    ],
    "funding": [
        "Ministry of Public Health",
        "Thai Health Promotion Foundation"
    ]
}